本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Cogent Biosciences, Inc.

7.29
+0.21002.97%
成交量:88.52萬
成交額:639.70萬
市值:8.31億
市盈率:-3.58
高:7.40
開:7.24
低:6.95
收:7.08
資料載入中...
2024/06/13

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/06/05

重要事件披露

Form 8-K - Current report
2024/05/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/07

重要事件披露

Form 8-K - Current report
2024/04/09

SEC問詢函

Form CORRESP - Correspondence
2024/04/01

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/03/27

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/03/22

重要事件披露

Form 8-K - Current report
2024/02/26

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/26

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/26

重要事件披露

Form 8-K - Current report
2024/02/16

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

重要事件披露

Form 8-K - Current report
2024/02/13

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/09

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]